• Search results for Pfizer
Image Title
covid-19-4961257_1280

The older you are, the more antibodies you'll have, finds Montreal researchers

In their study published in Scientific Reports, they observe that those who received the Pfizer BioNTech or AstraZeneca vaccine had antibody levels that were significantly higher than infected individ

Published on 9th November 2021
Covid_test_children_EPS

COVID vaccines for children aged 5 to 11 may be available as early as next month in the US

Gottlieb said on the CBS show “Face the Nation” that “in a best-case scenario,” the Pfizer vaccine could be ready by October 31 for younger children

Published on 13th September 2021
Vaccine_RGGH_EPS

COVID vaccines effective against Delta variant, can prevent hospitalisation: Study

The research that used national data also indicates that Moderna's vaccine is significantly more effective against Delta variant than Pfizer and Johnson & Johnson preventives

Published on 13th September 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Australia approves Pfizer-BioNTech COVID-19 vaccine for children aged 12 to 15

Health Minister Greg Hunt announced that the Therapeutic Goods Administration (TGA) has ruled that the Pfizer-BioNTech COVID-19 vaccine is safe for the age group

Published on 23rd July 2021
Vaccine_RGGH_EPS

Stanford School of Medicine study shows why you shouldn't skip the second dose of COVID-19 vaccine

The study was designed to find out exactly what effects the vaccine, marketed by Pfizer Inc, has on the numerous components of the immune response. 

Published on 20th July 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Those jabbed with Pfizer, Moderna COVID vaccines have a 91% chance of not getting the disease

The research, published in the New England Journal of Medicine on June 30, is among the first to show the benefits of mRNA vaccines even among those who experience breakthrough infections

Published on 7th July 2021
Covishield

Serum Institute requests government to get Covishield included in EU COVID-19 Vaccination Passport

Only four vaccines — Comirnaty of Pfizer/BioNTech, Moderna, Vaxzevria by AstraZeneca-Oxford and Johnson & Johnson's Janssen — have been approved by the European Medicines Agency (EMA) 

Published on 28th June 2021
Moderna_COVID-19_vaccine

Pfizer, Moderna COVID-19 vaccines do not harm male fertility, suggests study

The study, published on Thursday in the journal JAMA, recruited 45 healthy male volunteers aged 18 to 50 years scheduled for mRNA COVID-19 vaccination by Pfizer-BioNTech and Moderna

Published on 18th June 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

UK's drug regulator approves Pfizer BioNTech COVID vaccine for children above 12 years

The Medicines and Healthcare products Regulatory Agency (MHRA) said the decision followed a "rigorous review" of safety and effectiveness in the lower age groups 

Published on 4th June 2021
1604934611_pfizer-covid-19-vaccine

Pfizer jab produces less antibodies against Delta variant of the Coronavirus according to Lancet

For the study, the team analysed antibodies in the blood of 250 healthy people who received either one or two doses of the Pfizer-BioNTech COVID-19 vaccine, up to three months after their first dose

Published on 4th June 2021
vaccine-5873170_1920

Study suggests that COVID-19 vaccines may offer long-lasting protection against virus

Critical studies are underway, and evidence is mounting that immunity from the mRNA vaccines made by Pfizer and Moderna doesn't depend exclusively on antibodies that dwindle over time

Published on 3rd June 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Pfizer, BioNTech requests EU to approve its COVID vaccine for children between 12 and 15 

In a statement on Friday, the two companies said their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents

Published on 30th April 2021
Pfizer-BioNTech_COVID-19_vaccine_(2020)_C

Common bowel disease treatment may blunt COVID-19 vaccine response: Study

The study, published in the journal GUT, measured antibody response after vaccination with the Pfizer/BioNTech or the Oxford/AstraZeneca COVID-19 vaccine in 865 people treated with infliximab

Published on 27th April 2021
1604934611_pfizer-covid-19-vaccine

Pfizer offers COVID vaccine at 'not-for-profit' prices in India

Pfizer shared that it aims to provide equitable and affordable access to vaccines for people around the world. The company charges $19.5 per dose from the US government to supply the vaccine

Published on 22nd April 2021
1604934611_pfizer-covid-19-vaccine

Pfizer asks US to clear its COVID-19 vaccine for use in kids after releasing data supporting it

The request to expand emergency use comes just days after Pfizer released data demonstrating its vaccine was 100 per cent effective and well tolerated by the younger group

Published on 10th April 2021

Search results 1 - 15 of 102